Insights into recent findings and clinical application of YAP and TAZ in cancer

JM Franklin, Z Wu, KL Guan - Nature Reviews Cancer, 2023 - nature.com
Decades of research have mapped out the basic mechanics of the Hippo pathway. The
paralogues Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding …

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Q Li, Y Tie, A Alu, X Ma, H Shi - Signal transduction and targeted …, 2023 - nature.com
Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …

Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

O Novoplansky, AB Shnerb, D Marripati… - Molecular …, 2023 - Wiley Online Library
Blocking the mitogen‐activated protein kinase (MAPK) pathway with the MEK1/2 inhibitor
trametinib has produced promising results in patients with head and neck squamous cell …

Statins in cancer prevention and therapy

N Ricco, SJ Kron - Cancers, 2023 - mdpi.com
Simple Summary Retrospective studies of common malignancies such as head and neck
cancer often report lower incidence and/or better outcomes for patients incidentally treated …

How phosphofructokinase-1 promotes PI3K and YAP/TAZ in cancer: therapeutic perspectives

L Simula, M Alifano, P Icard - Cancers, 2022 - mdpi.com
Simple Summary We propose that PFK1 promotes a positive feedback loop with PI3K/AKT
and YAP/TAZ signaling pathways in cancer cells. Therefore, targeting PFK1 (or its product F …

Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases

PD Talukdar, U Chatterji - Signal Transduction and Targeted Therapy, 2023 - nature.com
Specific cell states in metazoans are established by the symphony of gene expression
programs that necessitate intricate synergic interactions between transcription factors and …

Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis

HL Thrash, AM Pendergast - Cancers, 2023 - mdpi.com
Simple Summary YAP and TAZ are both transcriptional co-activators in the Hippo pathway.
New evidence reveals that they have unique and overlapping functions during tumor …

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

RK Sahu, S Ruhi, AK Jeppu, HA Al-Goshae… - Frontiers in …, 2023 - frontiersin.org
The pathetic malignant mesothelioma (MM) is a extremely uncommon and confrontational
tumor that evolves in the mesothelium layer of the pleural cavities (inner lining-visceral …

EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma

J Bai, Y Chen, Y Sun, X Wang, Y Wang, S Guo… - Cellular and Molecular …, 2024 - Springer
Abstract Ephrin receptor A2 (EphA2), a member of the Ephrin receptor family, is closely
related to the progression of oral squamous cell carcinoma (OSCC). Cancer stem cells …

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

M Inchanalkar, S Srivatsa, S Ambatipudi, PG Bhosale… - Clinical …, 2023 - Springer
Background Gingivobuccal complex oral squamous cell carcinoma (GBC-OSCC) is an
aggressive malignancy with high mortality often preceded by premalignant lesions …